1.Calder, PC & Burdge, GC (2004) Fatty acids. In Bioactive Lipids, pp. 1–36 [Nicolaou, A and Kafatos, G, editors]. Bridgwater, Somerset: The Oily Press.
2.Gurr, MI, Harwood, JL & Frayn, KN (2002) Lipid Biochemistry: An Introduction, 5th ed. Oxford: Wiley-Blackwell.
3.Sprecher, H (2002) The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 67, 79–83.
4.Edgren, B & Wrtelind, A (1963) The theoretical background of the intravenous nutrition with fat emulsions. Nutr Dieta Eur Rev Nutr Diet 13, 364–386.
5.Hallberg, D, Schuberth, O & Wretlind, A (1966) Experimental and clinical studies with fat emulsion for intravenous nutrition. Nutr Dieta Eur Rev Nutr Diet 8, 245–281.
6.Wretlind, A (1972) Complete intravenous nutrition. Theoretical and experimental background. Nutr Metab (Lond) 14, Suppl., 1–57.
7.Heyland, DK, MacDonald, S, Keefe, L et al. (1998) Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 280, 2013–2019.
8.Koch, T & Heller, AR (2005) Auswirkungen einer parenteralen ernahrung mit n-3-fettsauren auf das therapieergebnis – eine multizentrische analyse bei 661 patienten (Effects of parenteral nutrition with n-3-fatty acids on the result of therapy – a multicentre analysis with 661 patients). Akt Ernahrungs 30, 15–22.
9.Calder, PC, Sherrington, EJ, Askanazi, J et al. (1994) Inhibition of lymphocyte proliferation in vitro by two lipid emulsions with different fatty acid compositions. Clin Nutr 13, 69–74.
10.Monson, JRT, Sedman, PC, Ramsden, CW et al. (1988) Total parenteral nutrition adversely influences tumour-directed cellular cytotoxic responses in patients with gastrointestinal cancer. Eur J Surg Oncol 14, 435–443.
11.Battistella, FD, Widergren, JT, Anderson, JT et al. (1997) A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 43, 52–58.
12.Furukawa, K, Yamamori, H, Takagi, K et al. (2002) Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 18, 235–240.
13.Dionigi, P, Dionigi, R, Prati, U et al. (1985) Effect of Intralipid® on some immunological parameters and leukocyte functions in patients with esophageal and gastric cancer. Clin Nutr 4, 229–234.
14.Gogos, CA, Kalfarentzos, FE & Zoumbos, NC (1990) Effect of different types of total parenteral nutrition on T-lymphocyte subpopulations and NK cells. Am J Clin Nutr 51, 119–122.
15.Sedman, PC, Somers, SS, Ramsden, CW et al. (1991) Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br J Surg 78, 1396–1399.
16.Lenssen, P, Bruemmer, BA, Bowden, RA et al. (1998) Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr 67, 927–933.
17.Calder, PC (2006) Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc 65, 264–277.
18.Ulrich, H, McCarthy Pastores, S, Katz, DP et al. (1996) Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 12, 231–238.
19.Adolph, M (1999) Lipid emulsions in parenteral nutrition. Ann Nutr Metab 43, 1–13.
20.Quiles, JL, Ramirez-Tortosa, MC & Yaqoob, P (2006) Olive Oil and Health. Wallingford, Oxon.: CABI.
21.Granato, D, Blum, S, Rössle, C et al. (2000) Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. JPEN J Parenter Enteral Nutr 24, 113–118.
22.Sala-Vila, A, Barbosa, VM & Calder, PC (2007) Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care 10, 165–174.
23.Thomas-Gibson, S, Jawhari, A, Atlan, P et al. (2004) Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure. Clin Nutr 23, 697–703.
24.Reimund, JM, Rahmi, G, Escalin, G et al. (2005) Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment Pharmacol Ther 21, 445–454.
25.Vahedi, K, Atlan, P, Joly, F et al. (2005) A 3-month double-blind randomised study comparing an olive oil- with a soyabean oil-based intravenous lipid emulsion in home parenteral nutrition patients. Br J Nutr 94, 909–916.
26.Cano, NJ, Saingra, Y, Dupuy, AM et al. (2006) Intradialytic parenteral nutrition: comparison of olive oil versus soybean oil-based lipid emulsions. Br J Nutr 95, 152–159.
27.Huschak, G, Zur Nieden, K, Hoell, T et al. (2005) Olive oil based nutrition in multiple trauma patients: a pilot study. Intensive Care Med 31, 1202–1208.
28.Mateu-de Antonio, J, Grau, S, Luque, S et al. (2008) Comparative effects of olive oil-based and soyabean oil-based emulsions on infection rate and leucocyte count in critically ill patients receiving parenteral nutrition. Br J Nutr 99, 846–854.
29.García-de-Lorenzo, A, Denia, R, Atlan, P et al. (2005) Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomised double-blind study of an olive oil-based lipid emulsion v. medium/long-chain triacylglycerols. Br J Nutr 94, 221–230.
30.Calder, PC (2004) N-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107, 1–11.
31.Kris-Etherton, PM, Harris, WS & Appel, LJ for the American Heart Association Nutrition Committee (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
32.Bucher, HC, Hengstler, P, Schindler, C et al. (2002) N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112, 298–304.
33.Studer, M, Briel, M, Leimenstoll, B et al. (2005) Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 165, 725–730.
34.Wang, C, Harris, WS, Chung, M et al. (2006) n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5–17.
35.Calder, PC (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
36.Tagawa, H, Shimokawa, H, Tagawa, T et al. (1999) Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease. J Cardiovasc Pharmacol 33, 633–640.
37.Calder, PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327–335.
38.Calder, PC (2008) Danone Chair Monograph: Omega-3 Fatty Acids – The Good Oil? Brussels: Institut Danone.
39.Furst, P & Kuhn, KS (2000) Fish oil emulsions: what benefits can they bring? Clin Nutr 19, 7–14.
40.Adolph, M (2001) Lipid emulsions in total parenteral nutrition – state of the art and future perspectives. Clin Nutr 20, Suppl. 4, 11–14.
41.Grimble, R (2005) Fatty acid profile of modern lipid emulsions: scientific considerations for creating the ideal composition. Clin Nutr Suppl 1, 9–15.
42.Grimm, H (2005) A balanced lipid emulsion – a new concept in parenteral nutrition. Clin Nutr Suppl 1, 25–30.
43.Morlion, BJ, Torwesten, E, Lessire, A et al. (1996) The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in postoperative trauma. Metabolism 45, 1208–1213.
44.Wachtler, P, Konig, W, Senkal, M et al. (1997) Influence of a total parenteral nutrition enriched with ω-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 42, 191–198.
45.Koller, M, Senkal, M, Kemen, M et al. (2003) Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr 22, 59–64.
46.Grimm, H, Mertes, N, Goeters, C et al. (2006) Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 45, 55–60.
47.Weiss, G, Meyer, F, Matthies, B et al. (2002) Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 87, S89–S94.
48.Schauder, P, Rohn, U, Schafer, G et al. (2002) Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. Br J Nutr 87, S103–S110.
49.Wichmann, MW, Thul, P, Czarnetzki, HD et al. (2007) Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 35, 700–706.
50.Tsekos, E, Reuter, C, Stehle, P et al. (2004) Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr 23, 325–330.
51.Heller, AR, Rossel, T, Gottschlich, B et al. (2004) Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 111, 611–616.
52.Berger, MM, Tappy, L, Revelly, JP et al. (2008) Fish oil after abdominal aorta aneurysm surgery. Eur J Clin Nutr 62, 1116–1122.
53.Mayer, K, Fegbeutel, C, Hattar, K et al. (2003) W-3 vs. W-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 29, 1472–1481.
54.Mayer, K, Gokorsch, S, Fegbeutel, C et al. (2003) Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 167, 1321–1328.
55.Heller, AR, Rössler, S, Litz, RJ et al. (2006) Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 34, 972–979.
56.Wang, X, Li, W, Li, N et al. (2008) Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr 32, 236–241.
57.Friesecke, S, Lotze, C, Köhler, J et al. (2008) Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 34, 1411–1420.